A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the benefits and risks of once-weekly dulaglutide
compared to once-daily liraglutide in participants with type 2 diabetes who have inadequate
glycemic control on metformin.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Dulaglutide Immunoglobulin Fc Fragments Liraglutide Metformin